News
COVID-19 vaccine: After Pfizer, SII, Bharat Biotech seeks emergency use authorisation for its Covaxin
Bharat Biotech had applied to the Drugs Controller General of India seeking emergency use authorisation for its Covid-19 vaccine Covaxin. The Pune-based Serum Institute of India (SII) had applied to the central drug regulator for emergency use authorisation of...
News
Sheremetyevo International handles Sputnik V vaccine shipment
Sheremetyevo International Airport was the launching point for an early batch of Russian Covid-19 vaccine Sputnik V. In total, 20 doses of the vaccine were transported from Moscow to Serbia where it will be used in clinical trials at...
Clinical Trials
Lilly’s tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes
Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type 2 diabetes after 40 weeks of treatment in topline results from Eli Lilly and Company's SURPASS-1 monotherapy clinical trial evaluating the efficacy and safety...
News
Merck Expands Life Science Production Capacities in the United States
Merck, a leading science and technology company, announced the broadening of its manufacturing footprint with a combined € 40 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, USA. These sites supply critical products to...
News
Aizon Lauded by Frost & Sullivan for Its AI-powered Platform that Enables Pharma Companies to Achieve Smart and Continuous Manufacturing
Based on its recent analysis of the North American artificial intelligence (AI) market for productivity and compliance in pharmaceuticals, Frost & Sullivan recognizes Aizon with the 2020 North American Enabling Technology Leadership Award. Aizon's good practice (GxP)-compliant, cloud-based, and...
News
CluePoints Opens New AsiaPac Office in Tokyo
CluePoints, the premier provider of Central Statistical Monitoring, Risk-Based Quality Management and Data Quality Oversight Software for clinical trials, announced further expansion in Japan with the opening of a new office in Tokyo. Dedicated to serving their Japanese clients,...
News
Piramal Pharma Solutions invests US$ 32 mn to expand Michigan facility
Piramal Pharma Limited’s pharma solutions business, a leading contract development and manufacturing organization (CDMO), is investing US$ 32 million to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of active pharmaceutical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















